None
Quote | Knight Therapeutics Inc (OTCMKTS:KHTRF)
Last: | $4.29 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $4.29 |
High: | $0 |
Low: | $0 |
Volume: | 2,200 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Knight Therapeutics Inc (OTCMKTS:KHTRF)
2024-05-11 03:53:01 ET Knight Therapeutics, Inc. (KHTRF) Q1 2024 Earnings Conference Call May 9, 2024, 8:30 am ET Company Participants Samira Sakhia - President & CEO Amal Khouri - CBO Arvind Utchanah - CFO Conference Call Participants Andre Uddin...
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has entered into an exclusive supply and distribution agreement with Ironshore Pharmaceuticals & Development, Inc., a wh...
Message Board Posts | Knight Therapeutics Inc (OTCMKTS:KHTRF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Knight Therapeutics Inc Company Name:
KHTRF Stock Symbol:
OTCMKTS Market:
Knight Therapeutics Inc Website:
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has entered into an exclusive supply and distribution agreement with Ironshore Pharmaceuticals & Development, Inc., a wh...
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2024. All currency amounts are in ...
MONTREAL, May 07, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 2024 R...